Office opening hours: 8.30am to 5.30pm Monday to Friday. Offices closed on Bank Holidays.
Home Menu Search

British Pharmaceutical Industry's Code of Practice

The pharmaceutical industry effectively self regulates and operates to the highest ethical standards as laid out in The Association of the British Pharmaceutical Industry’s Code of Practice for the Pharmaceutical Industry (the Code). 

The Code sets standards for the promotion of medicines to health professionals and appropriate administrative staff in the UK.  It includes requirements for the provision of information to patients and the public and relationships with patient groups. The Code also applies to a number of areas that are non-promotional.

The Code covers:

To help health professionals understand these requirements and others covered in the Code the PMCPA is launching an e-learning module (available at: and a Quick Guide to the Code for Health Professionals. The e-learning module is interactive and lays out how the pharmaceutical industry can promote medicines to health professionals. Key points from the Code covered in the e-learning module include the content of advertisements and arrangements for meetings. The e-learning module has been certified as meeting the guidelines for continuing professional development. 

The PMCPA has also published informal guidance on digital communication to help increase understanding on how the pharmaceutical industry can use this media. The promotion of prescription only medicines to the public is prohibited. Under the Code the industry can provide factual and balanced information to the public about prescription only medicines. The Medicines and Healthcare products Regulatory Agency (MHRA) has welcomed the PMCPA’s informal guidance. 

To assist in Code compliance, the pharmaceutical industry trains all of its employees from chief executives, through to marketing, sales, regulatory affairs and medical directors. Companies also regularly refer to the Code in their corporate responsibility documentation. Companies ruled in breach of the Code must withdraw the material at issue forthwith. Depending upon the circumstances a number of sanctions can be applied and details of the most serious breaches are publicised in advertisements in the medical, nursing and pharmaceutical press. Detailed reports on all complaints are published on the PMCPA website ( and in the Code of Practice Review. Rulings under the Code are made in the first instance by the Code of Practice Panel with both parties having the right to appeal those rulings to the Code of Practice Appeal Board. The industry takes breaches of the Code very seriously. 

Download and bookmark...

About this page...

Updated on 21 August 2017 1257 views